Rua Bioscience partners with PharmAla Biotech to distribute LaNeo MDMA in New Zealand
Bitget2026/10/08 20:16Rua Bioscience signed a distribution and license agreement to import and sell Pharmala Biotech Holdings’ GMP-grade LaNeo MDMA in New Zealand. Deal targets PTSD treatment following Medsafe’s Sept. 4, 2026 authorization for two psychiatrists to prescribe pharmaceutical-grade MDMA. Rua will supply 40 mg LaNeo MDMA capsules to authorized prescribers; initial shipment will be on consignment to limit upfront capital. PharmAla terminated its prior exclusive New Zealand distribution agreement with Veridion on Sept. 1, 2026, clearing the way for Rua. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmala Biotech Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081615PRIMZONEFULLFEED9841796) on October 08, 2026, and is solely responsible for the information contained therein.
- Rua Bioscience signed a distribution and license agreement to import and sell Pharmala Biotech Holdings’ GMP-grade LaNeo MDMA in New Zealand.
- Deal targets PTSD treatment following Medsafe’s Sept. 4, 2026 authorization for two psychiatrists to prescribe pharmaceutical-grade MDMA.
- Rua will supply 40 mg LaNeo MDMA capsules to authorized prescribers; initial shipment will be on consignment to limit upfront capital.
- PharmAla terminated its prior exclusive New Zealand distribution agreement with Veridion on Sept. 1, 2026, clearing the way for Rua.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
